IPO Listed

IMPACT Therapeutics IPO

HK$844m raised

Lodged 13 May 2026 · HKEX: 7630

Advisers

IMPACT Therapeutics

Issuer

Lead managers

Lead manager
CICC (co)
Joint lead manager
CICC (co)
Bookrunner
CICC (co)
Joint sponsors
CICC (co)
Issuer
IMPACT Therapeutics
Issuer based in
China
Listed
13 May 2026
Sector
Biotech
Tags
Biotech, Oncology, Drug Development

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.